Cargando…
Clinical Utility of the Ratio Between Circulating Fibrinogen and Fibrin (ogen) Degradation Products for Evaluating Coronary Artery Disease in Type 2 Diabetic Patients
BACKGROUND: We investigated whether and to what extent the ratio between circulating fibrinogen (Fg) and its degradation products (FDP) reflects the severity of coronary artery disease (CAD) in type 2 diabetic patients. METHODS: Plasma levels of Fg and FDP were determined, and Fg/FDP ratio was calcu...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833973/ https://www.ncbi.nlm.nih.gov/pubmed/25758263 http://dx.doi.org/10.4103/0366-6999.152465 |
_version_ | 1782427421722542080 |
---|---|
author | Xiong, Wei-Xin Shen, Ying Dai, Dao-Peng Lu, Lin Zhang, Qi Zhang, Rui-Yan Shen, Wei-Feng Tao, Rong |
author_facet | Xiong, Wei-Xin Shen, Ying Dai, Dao-Peng Lu, Lin Zhang, Qi Zhang, Rui-Yan Shen, Wei-Feng Tao, Rong |
author_sort | Xiong, Wei-Xin |
collection | PubMed |
description | BACKGROUND: We investigated whether and to what extent the ratio between circulating fibrinogen (Fg) and its degradation products (FDP) reflects the severity of coronary artery disease (CAD) in type 2 diabetic patients. METHODS: Plasma levels of Fg and FDP were determined, and Fg/FDP ratio was calculated in 344 consecutive patients with type 2 diabetes and chest pain on exertion undergoing coronary angiography. The severity of CAD was evaluated by the number of significant CAD (>50% luminal diameter narrowing) and Gensini score. RESULTS: Plasma Fg was higher, but Fg/FDP ratio was lower in patients with significant CAD (n = 255) compared with those without (n = 89), due to a disproportionate increase in FDP. Fg and FDP correlated positively, while Fg/FDP ratio negatively, with the number of diseased coronary arteries and the tertile of Gensini score (all P values for trend < 0.01). After adjusting for age, sex, risk factors for CAD, lipid profiles, glycosylated hemoglobin A1c, creatinine, leukocyte count, and high-sensitivity C-reactive protein, Fg/FDP ratio remained an independent determinant for multivessel coronary disease (MVD) (odds ratio [OR], 0.869; 95% confidence interval [CI], 0.788–0.958, P = 0.005) and high tertile of Gensini score (OR, 0.797, 95% CI, 0.682–0.930, P = 0.004). The area under the curve of Fg/FDP ratio was larger than that of Fg for predicting the presence of MVD (0.647 vs. 0.563, P = 0.048) and Gensini score ≥ 30 (0.656 vs. 0.538, P = 0.026). CONCLUSIONS: Elevated plasma Fg and FDP level and reduced Fg/FDP ratio are associated with presence of CAD, and Fg/FDP ratio is superior to Fg in reflecting severe coronary atherosclerosis for patients with type 2 diabetes. |
format | Online Article Text |
id | pubmed-4833973 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-48339732016-04-29 Clinical Utility of the Ratio Between Circulating Fibrinogen and Fibrin (ogen) Degradation Products for Evaluating Coronary Artery Disease in Type 2 Diabetic Patients Xiong, Wei-Xin Shen, Ying Dai, Dao-Peng Lu, Lin Zhang, Qi Zhang, Rui-Yan Shen, Wei-Feng Tao, Rong Chin Med J (Engl) Original Article BACKGROUND: We investigated whether and to what extent the ratio between circulating fibrinogen (Fg) and its degradation products (FDP) reflects the severity of coronary artery disease (CAD) in type 2 diabetic patients. METHODS: Plasma levels of Fg and FDP were determined, and Fg/FDP ratio was calculated in 344 consecutive patients with type 2 diabetes and chest pain on exertion undergoing coronary angiography. The severity of CAD was evaluated by the number of significant CAD (>50% luminal diameter narrowing) and Gensini score. RESULTS: Plasma Fg was higher, but Fg/FDP ratio was lower in patients with significant CAD (n = 255) compared with those without (n = 89), due to a disproportionate increase in FDP. Fg and FDP correlated positively, while Fg/FDP ratio negatively, with the number of diseased coronary arteries and the tertile of Gensini score (all P values for trend < 0.01). After adjusting for age, sex, risk factors for CAD, lipid profiles, glycosylated hemoglobin A1c, creatinine, leukocyte count, and high-sensitivity C-reactive protein, Fg/FDP ratio remained an independent determinant for multivessel coronary disease (MVD) (odds ratio [OR], 0.869; 95% confidence interval [CI], 0.788–0.958, P = 0.005) and high tertile of Gensini score (OR, 0.797, 95% CI, 0.682–0.930, P = 0.004). The area under the curve of Fg/FDP ratio was larger than that of Fg for predicting the presence of MVD (0.647 vs. 0.563, P = 0.048) and Gensini score ≥ 30 (0.656 vs. 0.538, P = 0.026). CONCLUSIONS: Elevated plasma Fg and FDP level and reduced Fg/FDP ratio are associated with presence of CAD, and Fg/FDP ratio is superior to Fg in reflecting severe coronary atherosclerosis for patients with type 2 diabetes. Medknow Publications & Media Pvt Ltd 2015-03-20 /pmc/articles/PMC4833973/ /pubmed/25758263 http://dx.doi.org/10.4103/0366-6999.152465 Text en Copyright: © 2015 Chinese Medical Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Xiong, Wei-Xin Shen, Ying Dai, Dao-Peng Lu, Lin Zhang, Qi Zhang, Rui-Yan Shen, Wei-Feng Tao, Rong Clinical Utility of the Ratio Between Circulating Fibrinogen and Fibrin (ogen) Degradation Products for Evaluating Coronary Artery Disease in Type 2 Diabetic Patients |
title | Clinical Utility of the Ratio Between Circulating Fibrinogen and Fibrin (ogen) Degradation Products for Evaluating Coronary Artery Disease in Type 2 Diabetic Patients |
title_full | Clinical Utility of the Ratio Between Circulating Fibrinogen and Fibrin (ogen) Degradation Products for Evaluating Coronary Artery Disease in Type 2 Diabetic Patients |
title_fullStr | Clinical Utility of the Ratio Between Circulating Fibrinogen and Fibrin (ogen) Degradation Products for Evaluating Coronary Artery Disease in Type 2 Diabetic Patients |
title_full_unstemmed | Clinical Utility of the Ratio Between Circulating Fibrinogen and Fibrin (ogen) Degradation Products for Evaluating Coronary Artery Disease in Type 2 Diabetic Patients |
title_short | Clinical Utility of the Ratio Between Circulating Fibrinogen and Fibrin (ogen) Degradation Products for Evaluating Coronary Artery Disease in Type 2 Diabetic Patients |
title_sort | clinical utility of the ratio between circulating fibrinogen and fibrin (ogen) degradation products for evaluating coronary artery disease in type 2 diabetic patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833973/ https://www.ncbi.nlm.nih.gov/pubmed/25758263 http://dx.doi.org/10.4103/0366-6999.152465 |
work_keys_str_mv | AT xiongweixin clinicalutilityoftheratiobetweencirculatingfibrinogenandfibrinogendegradationproductsforevaluatingcoronaryarterydiseaseintype2diabeticpatients AT shenying clinicalutilityoftheratiobetweencirculatingfibrinogenandfibrinogendegradationproductsforevaluatingcoronaryarterydiseaseintype2diabeticpatients AT daidaopeng clinicalutilityoftheratiobetweencirculatingfibrinogenandfibrinogendegradationproductsforevaluatingcoronaryarterydiseaseintype2diabeticpatients AT lulin clinicalutilityoftheratiobetweencirculatingfibrinogenandfibrinogendegradationproductsforevaluatingcoronaryarterydiseaseintype2diabeticpatients AT zhangqi clinicalutilityoftheratiobetweencirculatingfibrinogenandfibrinogendegradationproductsforevaluatingcoronaryarterydiseaseintype2diabeticpatients AT zhangruiyan clinicalutilityoftheratiobetweencirculatingfibrinogenandfibrinogendegradationproductsforevaluatingcoronaryarterydiseaseintype2diabeticpatients AT shenweifeng clinicalutilityoftheratiobetweencirculatingfibrinogenandfibrinogendegradationproductsforevaluatingcoronaryarterydiseaseintype2diabeticpatients AT taorong clinicalutilityoftheratiobetweencirculatingfibrinogenandfibrinogendegradationproductsforevaluatingcoronaryarterydiseaseintype2diabeticpatients |